Adaptable Proanthocyanidin Polymer Compositions for Congenital Diarrhea Disorder Treatment in Specialized Environments
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts proanthocyanidin polymer compositions for treating congenital diarrhea disorder to specific, niche environments, including disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration.
Background and Problem Solved
The original patent disclosed methods and compositions for treating congenital diarrhea disorder using proanthocyanidin polymer compositions. However, these compositions were not designed to address the unique challenges of specific, high-stress environments. This inventive concept solves the problem of adapting these compositions for use in disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration, where traditional formulations may be ineffective or impractical.
Detailed Description of the Inventive Concept
The inventive concept comprises proanthocyanidin polymer compositions specifically designed for use in specialized environments. These compositions may be formulated in portable, waterproof containers for disaster relief, secure, tamper-evident containers for high-security facilities, heat-stable, freeze-dried formulations for extreme weather conditions, or microgravity-compatible, hermetically sealed containers for space exploration. Additionally, the inventive concept may include portable kits for remote, off-grid locations, comprising a proanthocyanidin polymer composition, a water purification system, and a solar-powered refrigeration unit. These adaptations enable effective treatment of congenital diarrhea disorder in a variety of challenging environments.
Novelty and Inventive Step
The inventive concept's novelty lies in its adaptation of proanthocyanidin polymer compositions for specific, niche environments, which is not addressed by the original patent. The inventive step is the recognition of the need for specialized formulations and packaging to address the unique challenges of these environments, and the development of compositions and systems that meet these needs.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include formulations adapted for use in other specialized environments, such as tropical or desert environments, or for use in conjunction with other medical treatments. Variations may include different proanthocyanidin polymer compositions, alternative packaging materials or designs, or integration with other medical devices or systems.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of disaster relief, high-security healthcare, and space exploration. The market for these specialized compositions and systems is likely to be niche, but high-value, and may include government agencies, non-governmental organizations, and private companies operating in these environments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/353 |
| A | A61 | A61K9/0095 |
| A | A61 | A61K9/28 |
| A | A61 | A61K9/48 |
| A | A61 | A61P1/04 |
| A | A61 | A61P1/12 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions and medical treatment methods, specifically focused on gastrointestinal disorders, with expertise in drug formulation, delivery systems, and specialized medical interventions
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical scientist or medical researcher with advanced degrees in pharmacy, biochemistry, or medical sciences, possessing knowledge of drug delivery technologies, formulation strategies, and clinical treatment adaptations
Obviousness Rationale
A person having ordinary skill would recognize that the source patent's proanthocyanidin polymer composition for treating congenital diarrhea disorder provides a foundational framework that can be readily adapted to various environmental contexts. The PTD's variations represent predictable extensions of the original treatment method, applying known pharmaceutical formulation and packaging techniques to address specific use scenarios. The core therapeutic mechanism remains unchanged, with modifications focusing on delivery and preservation strategies that are well within the capabilities of a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,510 |
|---|---|
| Title | Methods and compositions for treating congenital diarrhea disorder |
| Assignee(s) | NAPO PHARMACEUTICALS, INC. |